Jennifer Check MD MS
High Risk Infant Follow-Up, Neonatal Neurodevelopment
Associate Professor, Pediatrics, Wake Forest School of Medicine
Join to View Full Profile
Atrium Health Wake Forest BaptistDept Pediatrics, Div Neonatology Medical Center BlvdWinston Salem, NC 27157
Phone+1 336-716-6214
Dr. Check is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jennifer Check is a neonatologist and perinatologist based in Winston Salem, NC, specializing in high-risk infant follow-up and neonatal neurodevelopment. She completed her fellowship in Neonatal-Perinatal Medicine at Ann and Robert H. Lurie Children's Hospital of Chicago at Northwestern University and her Pediatrics residency at the University of North Carolina Hospitals. Dr. Check holds a Master of Science in Clinical and Population Translational Sciences from Wake Forest University. She serves as an Associate Professor in the Department of Pediatrics at Atrium Health Wake Forest Baptist Brenner Children's Hospital. Her research includes publications on preterm infants' developmental and growth outcomes. She is involved in clinical trials, including those assessing the safety of sildenafil in premature infants with bronchopulmonary dysplasia.
Education & Training
Wake Forest UniversityMaster of Science, Clinical and Population Translational Sciences, 2013 - 2016
McGaw Medical Center of Northwestern UniversityFellowship, Neonatal-Perinatal Medicine, 2009 - 2012
University of North Carolina HospitalsResidency, Pediatrics, 2006 - 2009
University of North Carolina at Chapel Hill School of MedicineClass of 2006
Certifications & Licensure
NC State Medical License 2012 - 2025
IL State Medical License 2009 - 2014
American Board of Pediatrics Pediatrics- American Board of Pediatrics Neonatal-Perinatal Medicine
Clinical Trials
- Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia Start of enrollment: 2021 May 27
Roles: Contact
Publications & Presentations
PubMed
- 1 citationsNeonatal neurobehavior associated with developmental changes from age 2 to 3 in very preterm infants.Alexandrea L Craft, Marie Camerota, Cynthia Loncar, Brian S Carter, Jennifer Check
Early Human Development. 2024-07-01 - 1 citationsPreeclampsia, Fetal Growth Restriction, and 24-Month Neurodevelopment in Very Preterm Infants.Jennifer Check, Coral Shuster, Julie Hofheimer, Marie Camerota, Lynne M Dansereau
JAMA Network Open. 2024-07-01 - 2 citationsTwo-Year Autism Risk Screening and 3-Year Developmental Outcomes in Very Preterm Infants.Coral L Shuster, Stephen J Sheinkopf, Elisabeth C McGowan, Julie A Hofheimer, T Michael O'Shea
JAMA Pediatrics. 2024-02-01
Journal Articles
- Early growth outcomes in very low birth weight infants with bronchopulmonary dysplaisa or fetal growth restrictionCheck J, Jensen ET, Skelton JA, Ambrosius WT, O'Shea TM, Pediatric Research, 2/15/2020
Press Mentions
Using Buprenorphine to Treat Neonatal Abstinence Syndrome: A Quality Improvement StudyMarch 23rd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
